Digital Edition: MedTech Strategist June 2024

article image
ARTICLE SUMMARY:

VCs spot trends in medtech investing and dealmaking; the arguments for endobariatric weight-loss surgery in the GLP-1 agonist era: efficacy and cost-effectiveness; at the Safety in Spine Surgery Summit surgeons advocate for the safe use of enabling technologies and tending to their own mental health; L.E.K. Consulting on environmental sustainability in medtech. Plus profiles of Averto Medical and Synerfuse.

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: